← Home / Peptides / YourProtocol / KPV: Evidence, Legal Status, and Safety
Peptides Peptides

KPV: Evidence, Legal Status, and Safety

KPV is a tripeptide fragment of alpha-melanocyte-stimulating hormone (alpha-MSH), sold for gut and skin inflammation. The evidence is entirely preclinical: real, published animal and cell studies show it blocks NF-kB inflammatory signaling and reduces colitis in mice, but no completed human clinical trial exists. It has no FDA-approved use and no established legal pathway for human use; it is sold as an unregulated research chemical.

🧪
YourProtocol
YourProtocol Research
In-house · Synthesized from the cited primary sources
Daily time
5 min
Difficulty
Beginner
Sources
1
What the evidence says
What it is

Understand what's actually being sold

A 3-amino-acid fragment (lysine-proline-valine) of alpha-MSH that retains some of the parent hormone's anti-inflammatory activity, marketed for gut healing (IBD-adjacent claims) and skin or topical use.

Fragment peptides derived from a larger hormone do not automatically inherit the parent hormone's full safety or efficacy profile.

Dalmasso et al., "PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation," Gastroenterology, 2008 (PMID 18061177)
For this step
No product needed
Evidence tier: C

See what the evidence actually shows

Nanomolar concentrations of KPV inhibited NF-kB and MAP kinase inflammatory signaling and reduced DSS- and TNBS-induced colitis severity in mice; transport into cells occurs via the PepT1 di/tripeptide transporter. This is animal and cell data; no completed human trial was found.

Real, published preclinical evidence is not the same as clinical proof; this stays Tier C until human trial data exists.

Dalmasso et al., Gastroenterology, 2008 (PMID 18061177)
For this step
No product needed
Legal status

Know where it actually stands

Not FDA-approved for any human use; no prescription pathway exists; sold almost exclusively as an unregulated research chemical, not for human consumption. Some cosmetic formulations reference KPV as a topical ingredient, a separate, lower-bar regulatory category.

A cosmetic-ingredient listing is not equivalent to a reviewed medical use.

Research synthesis, 2026
For this step
No product needed
Safety

Know the real risk

No human safety data exists in any completed trial. Unregulated research-chemical sourcing carries the standard purity and contamination risk common to this whole category.

Without completed human trials, there is no independent basis for a safety claim in either direction.

Research synthesis, 2026
For this step
No product needed
What it is

KPV (lysine-proline-valine) is a 3-amino-acid fragment of alpha-melanocyte-stimulating hormone (alpha-MSH) that retains some of the parent hormone's anti-inflammatory activity. It is marketed for gut healing (IBD-adjacent claims) and skin or topical use. This page reports the honest evidence tier, legal status, and safety picture; it does not describe how to use it.

Why it worksâ–¼
The evidence base is animal and cell data. Nanomolar concentrations of KPV inhibited NF-kB and MAP kinase inflammatory signaling and reduced DSS- and TNBS-induced colitis severity in mice; transport into cells occurs via the PepT1 di/tripeptide transporter. All of this is animal and cell data; no completed human trial was found in this research pass. Some cosmetic formulations reference KPV as a topical ingredient, a different regulatory category (cosmetic, not drug) with its own much lower evidence bar.
The evidence
Sources 1
Primary sources behind this page, cited straight to the source: peer-reviewed papers and reporting. Select any to view it here.
1
PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation
Paper · Gastroenterology, 2008 (PMID 18061177)
Source viewer
Loading the first source…
Is this for you?
Good fit if
  • Anyone considering KPV who wants the honest evidence before discussing it with a clinician
  • Readers researching gut-inflammation peptides who have seen IBD-adjacent claims
  • Readers comparing KPV to FDA-approved peptides like semaglutide or tesamorelin
Cautions
  • Entirely preclinical evidence; no completed human clinical trial exists
  • Not FDA-approved for any human use; sold as an unregulated research chemical
  • No completed human trial registry entry was found for KPV in this research pass
  • Educational only, not medical advice
Common questions
Is KPV safe?▾
We do not know from human data; no completed human clinical trial exists. The evidence that does exist (animal and cell studies) shows anti-inflammatory activity but says nothing about human safety, and it is sold as an unregulated research chemical with no purity guarantee.
Has KPV been tested in humans?▾
Not in any completed, independently verifiable clinical trial found in this research pass. The evidence base is animal and cell studies (notably reduced colitis severity in mice).
Is KPV legal?▾
It is not FDA-approved for any human use and is sold as an unregulated research chemical, a legal gray area, not an approved medical product. Some cosmetic formulations list it as a topical ingredient, a separate, lower-evidence-bar category.
Related protocols
🧪
Peptides
BPC-157: Evidence, Legal Status, and Safety
Based on the work of YourProtocol
Get the next protocol first

New expert protocols and evidence updates, cited to the source. No spam; unsubscribe anytime.

Also good for: Heal Your Gut

Not medical advice. This page is for education only and is not a substitute for professional medical care. Consult a qualified clinician before changing your health routine.
Editorial disclosure. This protocol is written and fact-checked by the YourProtocol editorial team directly from the primary sources cited below; it is not written or reviewed by any outside expert.

KPV: Evidence, Legal Status, and Safety
Read the evidence
Read it